Business, energy, technology, markets and global industry news from Business News Today

gut-brain axis

Pharma & Biotech

Is Biocodex’s Fullify the first probiotic to challenge GLP-1 drugs in the consumer weight-loss space?

Biocodex launches Fullify, a gut-brain axis probiotic for appetite control. Find out what this means for weight loss, microbiome science, and the supplement industry.

Read More